Showing results (721-730 of 905) with videos related to

Sort By:
Pageof 91
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
The gut-liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune systemIrene Díaz-Alberola, Daniel E Di Zeo-Sánchez, Vanesa Garrido-Rodríguez, et al.
The Journal of Pathology|September 29, 2018
Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injuryMiguel E Zoubek, Marius M Woitok, Svenja Sydor, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1990
Incidence of localized cutaneous leishmaniasis (chiclero's ulcer) in MexicoF J Andrade-Narváez, E Simmonds-Díaz, S Rico-Aguilar, et al.
Pilot and Feasibility Studies|January 4, 2021
Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programmeH Gunn, K N Stevens, S Creanor, et al.
Memorias Do Instituto Oswaldo Cruz|June 12, 2024
The risk of vector transmission of Trypanosoma cruzi remains high in the State of ParanáJoão Vitor S Trovo, Michele Martha Weber-Lima, Bianca Prado-Costa, et al.
Hepatology (Baltimore, Md.)|January 11, 2022
A revised electronic version of RUCAM for the diagnosis of DILIPaul H Hayashi, M Isabel Lucena, Robert J Fontana, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 27, 2025
Genetic Variants of GBP4: Reduced Risks for Drug-Induced Acute Liver Failure in Non-Finnish European PopulationTsung-Jen Liao, Menghang Xia, Paul Hayashi, et al.
Gastroenterologia Y Hepatologia|February 22, 2011
[Virological response to adefovir dipivoxil predicts the long-term development of resistance in previously untreated patients with HBeAg-negative chronic hepatitis B]Emilio Suárez, Ana Gila, Blanca Figueruela, et al.
Pageof 91